Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Review
. 2013 Jan;21(1):333-41.
doi: 10.1007/s00520-012-1605-6. Epub 2012 Sep 22.

Systematic Review of Laser and Other Light Therapy for the Management of Oral Mucositis in Cancer Patients

Affiliations
Review

Systematic Review of Laser and Other Light Therapy for the Management of Oral Mucositis in Cancer Patients

Cesar Migliorati et al. Support Care Cancer. .

Abstract

Background: The aim of this study was to review the available literature and define clinical practice guidelines for the use of laser and other light therapies for the prevention and treatment of oral mucositis.

Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. Based on the evidence level, one of the following three guideline determinations was possible: recommendation, suggestion, and no guideline possible.

Results: A new recommendation was made for low-level laser (wavelength at 650 nm, power of 40 mW, and each square centimeter treated with the required time to a tissue energy dose of 2 J/cm(2) (2 s/point)) for the prevention of oral mucositis in adult patients receiving hematopoietic stem cell transplantation conditioned with high-dose chemotherapy, with or without total body irradiation. A new suggestion was made for low-level laser (wavelength around 632.8 nm) for the prevention of oral mucositis in patients undergoing radiotherapy, without concomitant chemotherapy, for head and neck cancer. No guideline was possible in other populations and for other light sources due to insufficient evidence.

Conclusions: The increasing evidence in favor of low-level laser therapy allowed for the development of two new guidelines supporting this modality in the populations listed above. Evidence for other populations was also generally encouraging over a range of wavelengths and intensities. However, additional well-designed research is needed to evaluate the efficacy of laser and other light therapies in various cancer treatment settings.

Similar articles

  • Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.
    Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Zadik Y, et al. Support Care Cancer. 2019 Oct;27(10):3969-3983. doi: 10.1007/s00520-019-04890-2. Epub 2019 Jul 8. Support Care Cancer. 2019. PMID: 31286228
  • Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
    Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Raber-Durlacher JE, et al. Support Care Cancer. 2013 Jan;21(1):343-55. doi: 10.1007/s00520-012-1594-5. Epub 2012 Sep 18. Support Care Cancer. 2013. PMID: 22987094 Review.
  • Systematic review of amifostine for the management of oral mucositis in cancer patients.
    Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Nicolatou-Galitis O, et al. Support Care Cancer. 2013 Jan;21(1):357-64. doi: 10.1007/s00520-012-1613-6. Epub 2012 Oct 3. Support Care Cancer. 2013. PMID: 23052919 Review.
  • MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
    Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Lalla RV, et al. Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25. Cancer. 2014. PMID: 24615748 Free PMC article. Review.
  • Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.
    Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Hong CHL, et al. Support Care Cancer. 2019 Oct;27(10):3949-3967. doi: 10.1007/s00520-019-04848-4. Epub 2019 Jul 8. Support Care Cancer. 2019. PMID: 31286232
See all similar articles

Cited by 52 articles

See all "Cited by" articles

References

    1. Cancer. 2004 May 1;100(9 Suppl):2026-46 - PubMed
    1. Pediatr Blood Cancer. 2007 Apr;48(4):435-40 - PubMed
    1. Support Care Cancer. 2008 Dec;16(12):1381-7 - PubMed
    1. J Clin Epidemiol. 1996 Jul;49(7):749-54 - PubMed
    1. Photomed Laser Surg. 2006 Apr;24(2):207-13 - PubMed

LinkOut - more resources

Feedback